GRNAW
Income statement / Annual
Last year (2022), GreenLight Biosciences Holdings's total revenue was $6.38 M,
and the percentage change from the previous year is not available.
In 2022, GreenLight Biosciences Holdings's net income was -$167.06 M.
See GreenLight Biosciences Holdings’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$6.38 M
|
$0.00
|
$962,000.00
|
$3.00 M
|
| Cost of Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$6.38 M |
$0.00 |
$962,000.00 |
$3.00 M |
| Gross Profit Ratio |
1 |
0 |
1 |
1 |
| Research and Development
Expenses |
$133.81 M
|
$89.83 M
|
$42.87 M
|
$23.49 M
|
| General & Administrative
Expenses |
$35.93 M
|
$20.32 M
|
$11.17 M
|
$8.71 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$35.93 M
|
$20.32 M
|
$11.17 M
|
$8.71 M
|
| Other Expenses |
-$396,000.00 |
-$1.60 M |
-$785,000.00 |
$0.00 |
| Operating Expenses |
$169.34 M |
$108.56 M |
$53.25 M |
$32.20 M |
| Cost And Expenses |
$169.34 M |
$108.56 M |
$53.25 M |
$32.20 M |
| Interest Income |
$895,000.00 |
$37,000.00 |
$83,000.00 |
$865,000.00 |
| Interest Expense |
$4.12 M |
$2.42 M |
$1.03 M |
$317,000.00 |
| Depreciation &
Amortization |
$9.93 M
|
$5.81 M
|
$1.84 M
|
$1.55 M
|
| EBITDA |
-$153.99 M
|
-$102.75 M
|
-$50.45 M
|
-$27.65 M
|
| EBITDA Ratio |
-24.12 |
0 |
-52.44 |
-9.21 |
| Operating Income Ratio
|
-25.68
|
0
|
-54.35
|
-9.73
|
| Total Other
Income/Expenses Net |
-$2.04 M
|
-$3.75 M
|
-$967,000.00
|
$553,000.00
|
| Income Before Tax |
-$165.96 M |
-$112.31 M |
-$53.25 M |
-$28.65 M |
| Income Before Tax Ratio
|
-26
|
0
|
-55.35
|
-9.55
|
| Income Tax Expense |
$1.09 M |
$2.42 M |
$1.03 M |
$317,000.00 |
| Net Income |
-$167.06 M |
-$114.73 M |
-$54.28 M |
-$28.97 M |
| Net Income Ratio |
-26.17 |
0 |
-56.42 |
-9.65 |
| EPS |
-1.27 |
-0.93 |
-0.56 |
-0.3 |
| EPS Diluted |
-1.27 |
-0.93 |
-0.56 |
-0.3 |
| Weighted Average Shares
Out |
$131.98 M
|
$122.82 M
|
$96.35 M
|
$96.35 M
|
| Weighted Average Shares
Out Diluted |
$131.98 M
|
$122.82 M
|
$96.35 M
|
$96.35 M
|
| Link |
|
|
|
|
